See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Repros Therapeutics (RPRX)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: RPRX
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on RPRX
Mike Havrilla
(1964 followers)
FDA Calendar Updates: Transcept Pharma Surges on Deal
(Mon, Aug 3)
FDA Calendar Updates: Repros, Discovery, Acorda, Human Genome Sciences
(Thu, Jul 2)
Five Extreme Biotech Trades
(Wed, Jun 10)
More by Mike Havrilla on RPRX »
Elliot Eisenberg
(3 followers)
Why Michelle Obama Is Likely to Support Repros Therapeutics
(Mon, Jul 13)
Five Reason Repros Therapeutics Is Hitting 52-Week Highs
(Fri, Jan 9)
What's With Efficacy Capital/Repros Therapeutics' Standstill Agreement?
(Tue, Jan 22)
More by Elliot Eisenberg on RPRX »
Centient Biotech Investor
(10 followers)
Biotech Day In Review: Cell Genesys Climbs On GVAX Results
(Wed, Apr 4)
Biotech Stocks Day-in-Review: Genentech Buys Altus' Pipeline
(Thu, Dec 21)
More by Centient Biotech Investor on RPRX »
Most followed authors on RPRX
Mike Havrilla
(1964 followers)
FDA Calendar Updates: Transcept Pharma Surges on Deal
(Mon, Aug 3)
FDA Calendar Updates: Repros, Discovery, Acorda, Human Genome Sciences
(Thu, Jul 2)
Five Extreme Biotech Trades
(Wed, Jun 10)
More by Mike Havrilla on RPRX »
optionMONSTER
(1283 followers)
A Three-Way Strategy on Repros Therapeutics
(Mon, Oct 26)
More by optionMONSTER on RPRX »
Frederic Ruffy
(643 followers)
Friday's Options Recap
(Fri, Aug 21)
Wednesday's Options Recap
(Wed, Jul 1)
More by Frederic Ruffy on RPRX »
Newest authors on RPRX
Biomaven
(1 follower)
Repros Therapeutics: Circling the Drain to Zero
(Wed, Sep 2)
More by Biomaven on RPRX »
M. E. Garza
(564 followers)
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
(Wed, Jul 1)
More by M. E. Garza on RPRX »
optionMONSTER
(1283 followers)
A Three-Way Strategy on Repros Therapeutics
(Mon, Oct 26)
More by optionMONSTER on RPRX »
Most commented on RPRX
Elliot Eisenberg
(3 followers)
Why Michelle Obama Is Likely to Support Repros Therapeutics
(Mon, Jul 13)
Five Reason Repros Therapeutics Is Hitting 52-Week Highs
(Fri, Jan 9)
What's With Efficacy Capital/Repros Therapeutics' Standstill Agreement?
(Tue, Jan 22)
More by Elliot Eisenberg on RPRX »
Biomaven
(1 follower)
Repros Therapeutics: Circling the Drain to Zero
(Wed, Sep 2)
More by Biomaven on RPRX »
Ian Bezek
(9 followers)
Red Flags at Repros Therapeutics
(Sun, Jan 25)
More by Ian Bezek on RPRX »